Zydus Lifesciences Ltd.
|
Balance Sheet
|
|
You can view the
Balance Sheet
for the last 5 years.
Market Cap. (Rs.)
|
95330.61 Cr.
|
P/BV
|
5.44
|
Book Value (Rs.)
|
174.07
|
52 Week High/Low (Rs.)
|
1032/485
|
FV/ML
|
1/1
|
P/E(X)
|
48.63
|
Bookclosure
|
28/07/2023
|
EPS (Rs.)
|
19.48
|
Div Yield (%)
|
0.63
|
|
(Rs. in Crs.)
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
No. of Equity Shares (in Lacs) | 10122.04 | 10237.43 | 10237.43 | 10237.43 | 10237.43 |
| | | | | |
EQUITIES AND LIABILITIES | | | | | |
SHAREHOLDER'S FUNDS | | | | | |
Equity Share Capital | 101.20 | 102.40 | 102.40 | 102.40 | 102.40 |
Total Share Capital | 101.20 | 102.40 | 102.40 | 102.40 | 102.40 |
| | | | | |
Reserves and Surplus | 17414.60 | 16897.20 | 12889.90 | 10273.30 | 10283.90 |
Total Reserves and Surplus | 17414.60 | 16897.20 | 12889.90 | 10273.30 | 10283.90 |
Total Shareholders Funds | 17515.80 | 16999.60 | 12992.30 | 10375.70 | 10386.30 |
Minority Interest | 2172.50 | 2054.20 | 1937.30 | 1334.70 | 1292.90 |
| | | | | |
NON-CURRENT LIABILITIES | | | | | |
Long Term Borrowings | 0.00 | 362.10 | 609.50 | 3214.60 | 3949.70 |
Deferred Tax Liabilities [Net] | 194.40 | 153.80 | 119.70 | 209.90 | 252.30 |
Other Long Term Liabilities | 71.20 | 61.30 | 55.10 | 47.10 | 75.30 |
Long Term Provisions | 271.80 | 325.00 | 309.50 | 235.20 | 184.10 |
Total Non-Current Liabilities | 537.40 | 902.20 | 1093.80 | 3706.80 | 4461.40 |
| | | | | |
CURRENT LIABILITIES | | | | | |
Short Term Borrowings | 1163.20 | 3833.90 | 3974.00 | 3826.50 | 3196.90 |
Trade Payables | 2125.00 | 2137.80 | 2205.90 | 2044.30 | 1922.60 |
Other Current Liabilities | 1877.10 | 1502.10 | 1351.50 | 2155.40 | 2087.30 |
Short Term Provisions | 365.40 | 365.60 | 329.90 | 243.20 | 135.70 |
Total Current Liabilities | 5530.70 | 7839.40 | 7861.30 | 8269.40 | 7342.50 |
| | | | | |
Total Capital And Liabilities | 25756.40 | 27795.40 | 23884.70 | 23686.60 | 23483.10 |
| | | | | |
ASSETS | | | | | |
NON-CURRENT ASSETS | | | | | |
Tangible Assets | 5696.50 | 5761.60 | 5550.00 | 5452.20 | 5105.90 |
Intangible Assets | 1020.00 | 1127.20 | 1236.30 | 1386.80 | 1768.80 |
Capital Work-In-Progress | 1130.20 | 661.00 | 783.20 | 741.50 | 837.20 |
Intangible Assets Under Development | 70.50 | 0.00 | 0.00 | 0.00 | 0.00 |
Fixed Assets | 7917.20 | 7549.80 | 7569.50 | 7580.50 | 7711.90 |
Goodwill On Consolidation | 4804.40 | 5364.60 | 5346.50 | 5391.50 | 5289.00 |
Non-Current Investments | 927.30 | 934.80 | 631.20 | 552.20 | 443.60 |
Deferred Tax Assets [Net] | 1262.40 | 1095.80 | 1074.40 | 852.90 | 970.30 |
Long Term Loans And Advances | 2.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Non-Current Assets | 826.70 | 589.00 | 547.10 | 594.10 | 570.20 |
Total Non-Current Assets | 15740.00 | 15534.00 | 15168.70 | 14971.20 | 14985.00 |
| | | | | |
| | | | | |
CURRENT ASSETS | | | | | |
Current Investments | 619.30 | 2353.20 | 198.90 | 212.80 | 229.90 |
Inventories | 3413.30 | 3719.40 | 3236.20 | 2789.00 | 2688.00 |
Trade Receivables | 4416.80 | 3340.30 | 3127.30 | 3663.20 | 3950.80 |
Cash And Cash Equivalents | 573.10 | 1106.90 | 888.30 | 964.90 | 548.90 |
Short Term Loans And Advances | 0.40 | 0.00 | 0.00 | 0.00 | 10.00 |
OtherCurrentAssets | 993.50 | 1741.60 | 1265.30 | 1085.50 | 1070.50 |
Total Current Assets | 10016.40 | 12261.40 | 8716.00 | 8715.40 | 8498.10 |
| | | | | |
Total Assets | 25756.40 | 27795.40 | 23884.70 | 23686.60 | 23483.10 |
| | | | | |
OTHER INFORMATION | | | | | |
| | | | | |
CONTINGENT LIABILITIES, COMMITMENTS | | | | | |
Contingent Liabilities | 1274.90 | 1210.70 | 1295.50 | 1053.70 | 930.00 |
| | | | | |
BONUS DETAILS | | | | | |
Bonus Equity Share Capital | 72.97 | 72.97 | 72.97 | 72.97 | 72.97 |
| | | | | |
NON-CURRENT INVESTMENTS | | | | | |
Non-Current Investments Quoted Market Value | 464.20 | 517.50 | 232.40 | 198.80 | 93.20 |
Non-Current Investments Unquoted Book Value | 46.50 | 43.00 | 41.80 | 1.80 | 2.00 |